Difesan +

Medical Device Class IIA. Single use.
Treatment useful for the maintenance and control of the physiological environment of the cervico-vaginal mucosa, to be used in all cases of temporary alteration of the vaginal microbial balance.
Indicated as an adjuvant for the maintenance of the physiological environment of the cervico-vaginal mucosa, é; useful for the prevention and treatment of cervico-vaginal infections and alterations that may arise during pregnancy and which can cause premature rupture of membranes, PROMs, shortening of the uterine cervix, and for the prevention of preterm birth.
Can; be useful:
- as an adjunct in the prevention of spontaneous abortion and preterm birth;
- as an adjuvant in the prevention against the increased risk of abortion linked to invasive procedures such as Amniocentesis or Villocentesis;
- as an adjuvant treatment useful in the prevention of preterm birth in the presence of reduced cervicometry or not corresponding to the gestational period;
- as an adjuvant in the prevention and treatment of infertility; female.

Modality; for use
After having carefully washed your hands, take a single tablet from the blister. Gently introduce the tablet into the vagina, the more; deeply possible. To facilitate the introduction of the vaginal tablet, it is suggested to lie in the supine position, with slightly bent legs. Treatment should be appropriately initiated and terminated in the inter-menstrual period or according to a different medical indication.

Components
Lactoferrin, Microcrystalline cellulose, Mannitol, Croscarmellose carboxymethylcellulose, Vegetable magnesium stearate, HPMC, Glycerol, Silicon dioxide.

Warnings
Single use; do not reuse. The product is; for vaginal use. Do not swallow. Do not use in case of hypersensitivity; and incompatibility; towards any component of the product. The tests carried out on the product to date have not shown sensitization phenomena or other side effects. In case of persistent discomfort, consult your doctor. Can; contain lactose. There are no studies on the use of the vaginal tablet in combination with local pharmacological therapies. The product is not; intended for pediatric use. Treatment should be appropriately initiated and terminated in the inter-menstrual period or according to a different medical indication. The maximum duration of continuous treatment is; 30 days. Prolonged use of the product, as with all topical products, can; give rise to sensitization phenomena or local irritation, where this; stop treatment and consult your doctor or pharmacist. Do not use the product if the package at the time of first opening is damaged or not perfectly intact. Use the product in accordance with the instructions for use. Keep the product out of sight and reach of children. Do not use the product after the expiry date indicated on the package.

Storage
Store at room temperature.
Validity; unopened: 24 months.

Format
Blister of 7 vaginal tablets of 0.9 g.